BPA Call HT942523A0001-HT009025FG0310021
Award Date
3/4/25
Potential Completion Date
9/30/25
Potential Value
$23K
Federal Agency
Defense Health Agency
Awardee
Cerilliant Corporation
Ultimate Awardee
Not listed
NAICS Category
325199 - All Other Basic Organic Chemical Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Round Rock, TX 78665, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the Defense Health Agency to procure drug testing kits from Cerilliant Corporation, a global leader in certified reference materials. The $15,015.91 fixed-price contract, awarded on January 27, 2025, will provide drug screening and confirmation test products to support the investigation and post-mortem testing of suspected drug use among U.S. service members. The contract has a period of performance through September 30, 2025 and is not designated as a...
This firm fixed-price contract award to Cerilliant Corporation, a foreign-owned for-profit manufacturer, is for the provision of drug standards that will be used for screening and testing of service members' specimens. The contract, valued at $12,538.24, was awarded by the Defense Health Agency on March 26, 2024, with a completion date of September 30, 2024. This appears to be a call under a larger Blanket Purchase Agreement (BPA) vehicle, as the contract type is listed as "BPA...
This firm-fixed-price purchase order contract was awarded by the Bureau of Medicine and Surgery (a part of the U.S. Department of Defense) to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference standards based in Round Rock, Texas. The $76,775.55 contract does not have a set-aside designation. Cerilliant has a history of providing essential reference materials and analytical standards to support various government healthcare, research, and...
This federal contract award to Cerilliant Corporation is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), valued at $15,522.70. The contract is for the provision of drug reference standards and calibration materials to support drug testing and screening of service member specimens, including post-mortem urine, blood, and tissue samples. The contract has a completion date of August 15, 2024 and is a firm fixed price arrangement. Cerilliant Corporation is a global...
Cerilliant Corporation, a foreign-owned manufacturer, was awarded a firm fixed price BPA call contract by the Defense Health Agency to provide products for screening and analysis of suspected drug use. The $12,175.61 contract has a completion date of September 30, 2024 and does not utilize any set-aside designations. Cerilliant is a long-standing federal contractor, delivering certified reference standards, reagents, and laboratory materials to support research, testing, and healthcare...
This federal contract award is a BPA (Blanket Purchase Agreement) call for drug reference standards and related supplies from Cerilliant Corporation, a global leader in certified reference materials. The contract has a total ceiling value of $9,906.25 and is awarded to Cerilliant by the Defense Health Agency (DHA), a defense agency within the Department of Defense. The contract delivers drug reference standards, calibrators, reagents, and laboratory materials to support research, testing,...
Cerilliant Corporation was awarded a firm fixed price call against the Defense Health Agency's blanket purchase agreement for the provision of $5,881.55 worth of reagent and laboratory supplies. As a global leader in reference standards and with over 30 years of experience supplying partners, Cerilliant will deliver certified chemical and biological reference materials to support testing and healthcare programs at the Defense Health Agency located in Fort Meade, Maryland. Cerilliant primarily...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price contract to Cerilliant Corporation, a global leader in providing certified reference standards, for the delivery of opioid kits. The $3,190,968.00 contract has a completion date of September 16, 2019. Cerilliant, a manufacturer of goods located in Round Rock, Texas, has extensive experience as a prime contractor providing chemical and biological reference standards, calibrators,...
The Department of the Army Medical Command awarded a firm fixed price blanket purchase agreement call contract valued at twenty thousand dollars to Cerilliant Corporation for certified drug reference standards. The contract has a period of performance through August 1, 2022 to support the Medical Command's drug testing and certification programs. Cerilliant will provide reference standards to the Medical Command's laboratories located at Fort Meade, Maryland to assist in their efforts to...
<p>The Department of the Army Medical Command awarded a firm fixed price blanket purchase agreement call contract to Cerilliant Corporation of Fort Meade, Maryland. The contract, valued at twenty thousand dollars, is for the delivery of certified drug reference standards to support Army medical programs. No set-aside provisions were applied to this award. Performance will take place in Fort Meade, with all work completed by July 2022.</p>